The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...

Shares of Pfizer Inc. gave up ground in early Tuesday trading, after the drug giant reported a decline in revenue, as ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

Pfizer COVID-19 vaccine sales drop 25% after confusing government guidance on the shot - Previously, fall is when Americans ...

The president’s call for removal of the metal from childhood inoculations set off alarms. About half of shots for polio, whooping cough and other diseases would be affected. By Christina Jewett ...

Pfizer is one of the world's largest pharmaceutical companies. It has a few material patent expirations on the horizon. It's doing what it has to do to deal with that headwind and others. Pfizer is ...

As has been the case each year since 2022, updated COVID-19 vaccines were released leading into the fall season, and the shots should be broadly available to people age 6 months and up. For the first ...

Pfizer is one of the largest pharmaceutical companies on the planet. It has a proven track record of finding, developing, and commercializing new drugs. The recent price advance is worth paying ...

The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House. By Rebecca Robbins and ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...